SCHEMBL13662907

SCHEMBL13662907

CCN(CC)c1ccc(N=Nc2cc(Br)ccc2O)c(O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 15/20 0.50
MAPT P10636 13/20 0.50
MEN1 O00255 7/20 0.50
KMT2A Q03164 7/20 0.50
GAA P10253 6/20 0.50
KDM4E B2RXH2 5/20 0.50
THRB P10828 2/20 0.50
MAPK1 P28482 2/20 0.50
RAB9A P51151 5/20 0.45
NPC1 O15118 3/20 0.43
LMNA P02545 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.40
HTT P42858 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
NPSR1 Q6W5P4 2/20 0.39
BLM P54132 1/20 0.39
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13662910 0.87 ALDH1A1 (0.44) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL13662906 0.84 KCNH2 (0.52) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL13662903 0.83 L3MBTL1 (0.48) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL272970 0.80 KCNH2 (0.47) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL29397420 0.80 KCNH2 (0.47) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL272969 0.80 KCNH2 (0.47) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL29397508 0.80 KCNH2 (0.47) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL13531277 0.80 KCNH2 (0.40) ALDH1A1MAPTMEN1KMT2AGAA
Bromide SCHEMBL30705401 0.79 KCNH2 (0.48) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL8206882 0.79 KCNH2 (0.46) ALDH1A1MAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090269543-A1 OPTICAL RECORDING MEDIUM TDK CORPORATION (JP) 2009-10-29 US disclosed
US-20090269543-A1 OPTICAL RECORDING MEDIUM TDK CORPORATION (JP) 2009-10-29 US disclosed
US-20090226658-A1 Optical Recording Medium TDK CORPORATION (JP) 2009-09-10 US disclosed
US-20090226658-A1 Optical Recording Medium TDK CORPORATION (JP) 2009-09-10 US disclosed
US-20090149660-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIA TDK CORPORATION (JP) 2009-06-11 US disclosed
US-20090149660-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIA TDK CORPORATION (JP) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149660-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIA KCNN4, CACNA1E, KCNN2 ALDH1A1 1253/4885MAPT 1924/4885MEN1 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.